Assessing human lung pharmacokinetics using exhaled breath particles (PEx)
O. Holz (Hannover, Germany), M. Sadiq (Gothenburg, Sweden), J. Nehrig (Hannover, Germany), B. Ellinghusen (Hannover, Germany), N. Struß (Hannover, Germany), U. Eriksson (Gothenburg, Sweden), M. Fridén (Gothenburg, Sweden), S. Stomilovic (Gothenburg, Sweden), A. Lundqvist (Gothenburg, Sweden), J. Hohlfeld (Hannover, Germany)
Source: International Congress 2022 – Chronic cough, airway diseases and methods
Session: Chronic cough, airway diseases and methods
Session type: Thematic Poster
Number: 172
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Holz (Hannover, Germany), M. Sadiq (Gothenburg, Sweden), J. Nehrig (Hannover, Germany), B. Ellinghusen (Hannover, Germany), N. Struß (Hannover, Germany), U. Eriksson (Gothenburg, Sweden), M. Fridén (Gothenburg, Sweden), S. Stomilovic (Gothenburg, Sweden), A. Lundqvist (Gothenburg, Sweden), J. Hohlfeld (Hannover, Germany). Assessing human lung pharmacokinetics using exhaled breath particles (PEx). 172
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|